Sonova (OTCMKTS:SONVY) Sets New 52-Week High – Here’s Why

Shares of Sonova Holding (OTCMKTS:SONVY) hit a new 52-week high on Monday. The company traded as high as $69.66 and last traded at $69.66, with a volume of 739 shares traded. The stock had previously closed at $68.25.

Analyst Upgrades and Downgrades

Several research firms have commented on SONVY. The Goldman Sachs Group upgraded Sonova from a “hold” rating to a “buy” rating in a research report on Thursday, October 8th. UBS Group upgraded Sonova from a “hold” rating to a “buy” rating in a report on Wednesday, July 22nd. Finally, Citigroup reaffirmed a “sell” rating on shares of Sonova in a research note on Friday, July 24th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Sonova presently has a consensus rating of “Moderate Buy”.

Sonova Stock Performance

The company has a fifty day simple moving average of $61.18 and a 200 day simple moving average of $53.20. The company has a current ratio of 1.75, a quick ratio of 1.43 and a debt-to-equity ratio of 0.51.

Sonova Company Profile

Sonova Holding AG is a Switzerland-based hearing-care company that develops, manufactures and distributes solutions for people with hearing loss. Its portfolio includes hearing aids, cochlear implants, hearing implants, wireless communication products and related accessories and services.

The company markets products under several brands, including Phonak, Unitron and Advanced Bionics. Sonova also operates hearing-care businesses and retail networks that provide hearing assessments, device fitting, rehabilitation support and after-sales services.